Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.150
0.00 (0.00%)
Oct 24, 2025, 4:00 PM EDT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of $4.56 billion as of October 27, 2025. Its market cap has increased by 13.47% in one year.
Market Cap
4.56B
Enterprise Value
4.18B
Revenue
828.10M
Ranking
n/a
PE Ratio
1.47
Stock Price
$2.15
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 4.56B, an increase of 1,575.20%. That is a compound annual growth rate of 33.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 4.56B | 68.07% |
| Dec 31, 2024 | 2.72B | -49.68% |
| Dec 29, 2023 | 5.40B | -19.93% |
| Dec 30, 2022 | 6.74B | -27.50% |
| Dec 31, 2021 | 9.30B | 227.16% |
| Dec 31, 2020 | 2.84B | -33.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |